Article
Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk.
Cancer research - 15 Jun 2007
Yaspan Brian L, Breyer Joan P, Cai Qiuyin, Dai Qi, Elmore J Bradford, Amundson Isaac, Bradley Kevin M, Shu Xiao-Ou, Gao Yu-Tang, Dupont William D, Zheng Wei, Smith Jeffrey R
Abstract excerpt
The CYP11A1 gene encodes the cholesterol side chain cleavage enzyme that catalyzes the initial and rate-limiting step of steroidogenesis. A large number of epidemiologic studies have implicated the duration and degree of endogenous estrogen exposure in the development of breast cancer in women. Here, we conduct a systematic investigation of the role of genetic variation of the CYP11A1 gene in breast cancer risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
